Ethan Sokol

15PUBLICATIONS
180CO-AUTHORS
Molecular targetsCancer cell biologyHaematological tumoursPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 08, 2026
Deficiency in POLE Exonuclease Causes Synthetic Lethality in Highly Aneuploid Cancer Cells.

|Mar 23, 2026
The Pan-Tumor Landscape of Gene Amplifications and Copy Number Amplification Ratio for Established and Emerging Clinical Targets.

Jessica K Lee, Julia C F Quintanilha, Kuei-Ting Chen

|Jan 09, 2026
Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition.

Joseph L Sottnik, Madeleine T Shackleford, Camryn S Nesiba

|Oct 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

Dejan Juric, Kyung Song, Radia M Johnson

|Sep 23, 2025
EML4-ALK Variant-Specific Genetic Interactions Shape Lung Tumorigenesis.

Alberto Diaz-Jimenez, Emily G Shuldiner, Kalman Somogyi

|May 09, 2025
Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancer.

Xueping Qu, Habib Hamidi, Radia M Johnson

Pageof 3

Frequent Collaborators

6 joint publications

Smruthy Sivakumar

3 joint publications

Alexa B Schrock

3 joint publications

Jeffrey S Ross

3 joint publications

Ryon P Graf